XML 40 R5.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statement of Equity - USD ($)
$ in Thousands
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Distributions in Excess of Accumulated Earnings [Member]
Accumulated Other Comprehensive Loss, Net [Member]
Noncontrolling Interest [Member]
Balance at period beginning at Dec. 31, 2017 $ 6,396,825 $ 7 $ 7,129,571 $ (833,726) $ (18,446) $ 119,419
Balances (in shares) at Dec. 31, 2017   66,054,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 289,159     272,333   16,826
Reversal of unrealized gains upon the sale of marketable debt securities 6       6  
Change in fair value of derivatives and amortization of swap settlements 12,630       12,210 420
Change in fair value of marketable debt securities, net (87)       (84) (3)
Issuance of common stock under:            
Stock option and restricted stock plans, net 2,751   2,751      
Stock option and restricted stock plans, net (in shares)   17,000        
Sale of common stock, net (483)   (483)      
Equity based compensation costs 8,561   7,697     864
Retirement of common stock, net (3,774)   (3,774)      
Retirement of common stock, net (in shares)   (17,000)        
Changes in the redemption value of redeemable noncontrolling interest (2,253)   (2,032)     (221)
Distributions to noncontrolling interest (22,281)         (22,281)
Redemptions of noncontrolling interest (157)   (143)     (14)
Redemptions of noncontrolling interest (in shares)   1,000        
Common stock dividends (368,577)     (368,577)    
Balance at period end at Sep. 30, 2018 6,436,028 $ 7 7,133,587 (808,085) (8,548) 119,067
Balances (in shares) at Sep. 30, 2018   66,055,000        
Balance at period beginning at Jun. 30, 2018 6,474,683 $ 7 7,131,809 (766,193) (11,438) 120,498
Balances (in shares) at Jun. 30, 2018   66,050,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 86,110     80,975   5,135
Reversal of unrealized gains upon the sale of marketable debt securities 4       4  
Change in fair value of derivatives and amortization of swap settlements 2,974       2,875 99
Change in fair value of marketable debt securities, net 12       11 1
Issuance of common stock under:            
Stock option and restricted stock plans, net 887   887      
Stock option and restricted stock plans, net (in shares)   5,000        
Sale of common stock, net (130)   (130)      
Equity based compensation costs 1,747   1,496     251
Changes in the redemption value of redeemable noncontrolling interest (408)   (386)     (22)
Distributions to noncontrolling interest (6,884)         (6,884)
Redemptions of noncontrolling interest (100)   (89)     (11)
Common stock dividends (122,867)     (122,867)    
Balance at period end at Sep. 30, 2018 6,436,028 $ 7 7,133,587 (808,085) (8,548) 119,067
Balances (in shares) at Sep. 30, 2018   66,055,000        
Issuance of common stock under:            
Cumulative effect upon adoption of ASU No. 2017-12         175  
Balance at period beginning at Dec. 31, 2018 6,393,844 $ 7 7,093,079 (812,796) (13,217) 126,771
Balances (in shares) at Dec. 31, 2018   65,890,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 329,266     310,468   18,798
Reversal of unrealized gains upon the sale of marketable debt securities (32)       (31) (1)
Change in fair value of derivatives and amortization of swap settlements (6,366)       (6,152) (214)
Change in fair value of marketable debt securities, net 203       197 6
Issuance of common stock under:            
Stock option and restricted stock plans, net 32,907   32,907      
Stock option and restricted stock plans, net (in shares)   188,000        
Sale of common stock, net 72,549 $ 73,400 72,549      
Sale of common stock, net (in shares)   228,271        
Equity based compensation costs 7,914   7,016     898
Retirement of common stock, net (56,989)   (56,989)      
Retirement of common stock, net (in shares)   (234,000)        
Changes in the redemption value of redeemable noncontrolling interest (3,675)   (5,048)     1,373
Changes in noncontrolling interest from acquisition 65,472         65,472
Distributions to noncontrolling interest (20,897)         (20,897)
Redemptions of noncontrolling interest (14,180)   (11,872)     (2,308)
Redemptions of noncontrolling interest (in shares)   10,000        
Common stock dividends (385,193)     (385,193)    
Balance at period end at Sep. 30, 2019 6,415,004 $ 7 7,131,642 (887,521) (19,028) 189,904
Balances (in shares) at Sep. 30, 2019   66,082,000        
Balance at period beginning at Jun. 30, 2019 6,345,116 $ 7 7,031,886 (857,994) (18,992) 190,209
Balances (in shares) at Jun. 30, 2019   65,727,000        
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net income 105,700     99,335   6,365
Change in fair value of derivatives and amortization of swap settlements (12)       (12) 0
Change in fair value of marketable debt securities, net (25)       (24) (1)
Issuance of common stock under:            
Stock option and restricted stock plans, net 27,679   27,679      
Stock option and restricted stock plans, net (in shares)   126,000        
Sale of common stock, net 72,631   72,631      
Sale of common stock, net (in shares)   228,000        
Equity based compensation costs 1,814   1,544     270
Changes in the redemption value of redeemable noncontrolling interest (2,247)   (2,309)     62
Distributions to noncontrolling interest (6,789)         (6,789)
Redemptions of noncontrolling interest (1)   211     (212)
Redemptions of noncontrolling interest (in shares)   1,000        
Common stock dividends (128,862)     (128,862)    
Balance at period end at Sep. 30, 2019 $ 6,415,004 $ 7 $ 7,131,642 $ (887,521) $ (19,028) $ 189,904
Balances (in shares) at Sep. 30, 2019   66,082,000